• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

星形胶质细胞反应性影响临床前阿尔茨海默病中淀粉样β蛋白和tau生物标志物的关联。

Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's disease.

作者信息

Pascoal Tharick, Bellaver Bruna, Povala Guilherme, Ferreira Pamela, Ferrari-Souza João Pedro, Leffa Douglas, Lussier Firoza, Benedet Andrea, Ashton Nicholas, Triana-Baltzerz Gallen, Kolbzh Hartmuth, Tissot Cèile, Therriault Joseph, Servaes Stijn, Stevenson Jenna, Rahmouni Nesrine, Lopez Oscar, Tudorascu Dana, Villemagne Victor, Ikonomovic Milos, Gauthier Serge, Zimmer Eduardo, Zetterberg Henrik, Blennow Kaj, Aizenstein Howard, Klunk William, Snitz Beth, Maki Pauline, Thurston Rebecca, Cohen Ann, Ganguli Mary, Karikari Thomas, Rosa-Neto Pedro

机构信息

University of Pittsburgh.

Universidade Federal do Rio Grande do Sul.

出版信息

Res Sq. 2023 Feb 1:rs.3.rs-2507179. doi: 10.21203/rs.3.rs-2507179/v1.

DOI:10.21203/rs.3.rs-2507179/v1
PMID:36778243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9915798/
Abstract

An unresolved question for the understanding of Alzheimer's disease (AD) pathophysiology is why a significant percentage of amyloid β (Aβ)-positive cognitively unimpaired (CU) individuals do not develop detectable downstream tau pathology and, consequently, clinical deterioration. evidence suggests that reactive astrocytes are key to unleashing Aβ effects in pathological tau phosphorylation. In a large study ( =1,016) across three cohorts, we tested whether astrocyte reactivity modulates the association of Aβ with plasma tau phosphorylation in CU people. We found that Aβ pathology was associated with increased plasma phosphorylated tau levels only in individuals positive for astrocyte reactivity (Ast+). Cross-sectional and longitudinal tau-PET analysis revealed that tau tangles accumulated as a function of Aβ burden only in CU Ast+ individuals with a topographic distribution compatible with early AD. Our findings suggest that increased astrocyte reactivity is an important upstream event linking Aβ burden with initial tau pathology which might have implications for the biological definition of preclinical AD and for selecting individuals for early preventive clinical trials.

摘要

在理解阿尔茨海默病(AD)病理生理学方面,一个尚未解决的问题是,为什么相当一部分淀粉样β(Aβ)阳性的认知未受损(CU)个体没有出现可检测到的下游tau病理变化,因此也没有出现临床恶化。有证据表明,反应性星形胶质细胞是在病理性tau磷酸化过程中释放Aβ效应的关键因素。在一项针对三个队列的大型研究(n = 1016)中,我们测试了星形胶质细胞反应性是否调节CU个体中Aβ与血浆tau磷酸化之间的关联。我们发现,仅在星形胶质细胞反应性阳性(Ast+)的个体中,Aβ病理与血浆磷酸化tau水平升高相关。横断面和纵向tau-PET分析显示,仅在具有与早期AD相符的地形分布的CU Ast+个体中,tau缠结随着Aβ负担的增加而累积。我们的研究结果表明,星形胶质细胞反应性增加是将Aβ负担与初始tau病理联系起来的重要上游事件,这可能对临床前AD的生物学定义以及为早期预防性临床试验选择个体具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f52f/9915798/bb9e283ccfc9/nihpp-rs2507179v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f52f/9915798/7869ac3b5e58/nihpp-rs2507179v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f52f/9915798/bb9e283ccfc9/nihpp-rs2507179v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f52f/9915798/7869ac3b5e58/nihpp-rs2507179v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f52f/9915798/bb9e283ccfc9/nihpp-rs2507179v1-f0002.jpg

相似文献

1
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's disease.星形胶质细胞反应性影响临床前阿尔茨海默病中淀粉样β蛋白和tau生物标志物的关联。
Res Sq. 2023 Feb 1:rs.3.rs-2507179. doi: 10.21203/rs.3.rs-2507179/v1.
2
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.星形胶质细胞反应影响了淀粉样蛋白-β对临床前阿尔茨海默病中 tau 病理的影响。
Nat Med. 2023 Jul;29(7):1775-1781. doi: 10.1038/s41591-023-02380-x. Epub 2023 May 29.
3
Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease.星形胶质细胞反应性与阿尔茨海默病中的 tau 缠结负荷和皮质变薄有关。
Mol Neurodegener. 2024 Jul 30;19(1):58. doi: 10.1186/s13024-024-00750-8.
4
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.血浆 GFAP 是阿尔茨海默病中淀粉样-β但不是 tau 病理学的早期标志物。
Brain. 2021 Dec 16;144(11):3505-3516. doi: 10.1093/brain/awab223.
5
Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile.认知功能正常且 Aβ 病理负担较低的个体具有独特的 CSF 生物标志物特征。
Alzheimers Res Ther. 2021 Jul 27;13(1):134. doi: 10.1186/s13195-021-00863-y.
6
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.基于生物标志物的阿尔茨海默病纵向 Tau 正电子发射断层扫描预测。
JAMA Neurol. 2022 Feb 1;79(2):149-158. doi: 10.1001/jamaneurol.2021.4654.
7
Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer's disease.血浆中β-突触核蛋白水平升高表明阿尔茨海默病早期突触退化。
Alzheimers Dement. 2023 Nov;19(11):5095-5102. doi: 10.1002/alz.13103. Epub 2023 Apr 27.
8
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.星形胶质细胞生物标志物 GFAP 和 YKL-40 介导早发性阿尔茨海默病的进展。
Alzheimers Dement. 2024 Jan;20(1):483-493. doi: 10.1002/alz.13450. Epub 2023 Sep 10.
9
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
10
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease.血浆 N 端包含 tau 片段(NTA-tau):阿尔茨海默病 tau 沉积的生物标志物。
Mol Neurodegener. 2024 Feb 17;19(1):19. doi: 10.1186/s13024-024-00707-x.

本文引用的文献

1
Biomarker modeling of Alzheimer's disease using PET-based Braak staging.使用基于 PET 的 Braak 分期对阿尔茨海默病的生物标志物建模。
Nat Aging. 2022 Jun;2(6):526-535. doi: 10.1038/s43587-022-00204-0. Epub 2022 Apr 25.
2
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
3
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.淀粉样蛋白和 tau 正电子发射断层扫描(PET)阳性、认知正常的个体未来认知能力下降的风险较高。
Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.
4
Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women.绝经后血管舒缩症状与中年女性的脑白质高信号
Neurology. 2023 Jan 10;100(2):e133-e141. doi: 10.1212/WNL.0000000000201401. Epub 2022 Oct 12.
5
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease.血浆 p-tau231 和 p-tau217 作为临床前阿尔茨海默病淀粉样β病理的状态标志物。
Nat Med. 2022 Sep;28(9):1797-1801. doi: 10.1038/s41591-022-01925-w. Epub 2022 Aug 11.
6
Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.5 年后 Tau PET 正常的淀粉样蛋白阳性个体特征:ADNI 研究。
Neurology. 2022 May 31;98(22):e2282-e2292. doi: 10.1212/WNL.0000000000200287. Epub 2022 Mar 21.
7
Astrocytic α2-Na/K ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model.星形胶质细胞 α2-Na/K ATP 酶抑制可抑制星形胶质细胞反应性并减少 tau 病小鼠模型中的神经退行性变。
Sci Transl Med. 2022 Feb 16;14(632):eabm4107. doi: 10.1126/scitranslmed.abm4107.
8
Connectomics in Brain Aging and Dementia - The Background and Design of a Study of a Connectome Related to Human Disease.脑衰老与痴呆中的连接组学——一项与人类疾病相关的连接组研究的背景与设计
Front Aging Neurosci. 2021 Oct 7;13:669490. doi: 10.3389/fnagi.2021.669490. eCollection 2021.
9
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.血浆和脑脊液神经胶质纤维酸性蛋白水平在阿尔茨海默病连续谱中的差异。
JAMA Neurol. 2021 Dec 1;78(12):1471-1483. doi: 10.1001/jamaneurol.2021.3671.
10
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.血浆 GFAP 是阿尔茨海默病中淀粉样-β但不是 tau 病理学的早期标志物。
Brain. 2021 Dec 16;144(11):3505-3516. doi: 10.1093/brain/awab223.